epigallocatechin gallate has been researched along with Obesity in 98 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (15.31) | 29.6817 |
| 2010's | 64 (65.31) | 24.3611 |
| 2020's | 19 (19.39) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, Y; Haseda, A; Hattori, H; Kondo, S; Kumazoe, M; Nakasone, A; Nishihira, J; Shimamoto, Y; Tachibana, H; Yamamoto, M; Yonekura, M; Yoshitomi, R | 1 |
| Benlloch, M; Ceron, JJ; de la Rubia Ortí, JE; Platero, JL; Sabater, PS; Sancho, S; Sancho-Cantus, D; Tvarijonaviciute, A; Yang, IH | 1 |
| Du, C; Han, Q; Ji, X; Li, C; Wang, Y; Wu, W; Xu, H; Xu, Y; Zhang, P | 1 |
| Gu, Q; Qian, L; Shen, X; Wang, X; Xie, L; Yao, X; Yu, Z | 1 |
| Bruno, RS; Dey, P; Sun, X; Zhu, J | 1 |
| Fang, L; Huang, J; Ou, K; Song, J; Wang, C; Wang, Q; Xia, S; Zhang, S | 1 |
| Cheng, H; Guo, H; Li, D; Li, Z; Wu, G; Xie, Z | 1 |
| James, A; Wang, K; Wang, Y | 1 |
| Gao, J; Hao, S; Jiang, P; Li, F | 1 |
| Bao, J; Chen, F; Chen, J; Gan, W; Ren, K; Wang, M; Wang, T; Yu, P; Zhang, F; Zhang, Z | 1 |
| Hochstetter, D; Mao, L; Wang, Y; Xu, P; Yao, L; Zhao, Y; Zhou, J | 1 |
| Kukk, K; Lookene, A; Reimund, M; Risti, R; Samel, N; Villo, L | 1 |
| Dias, DA; Gill, H; Hung, A; Lenon, GB; Li, M; Luo, S; Nguyen, LT | 1 |
| Berry, DL; Cheema, A; Chung, FL; Coia, H; Cruz, MI; Girgis, M; Hou, Y; Lee, Y; Ma, N; Pannkuk, E; Permaul, E; Rodriquez, O; Zhu, Z | 1 |
| Iacobazzi, D; Montagnani, M; Potenza, MA; Sgarra, L | 1 |
| Guan, Y; Li, Y; Ling, F; Liu, J; Niu, Y; Wu, Y; Yuan, H; Zhang, D; Zhu, Q | 1 |
| Chatree, S; Churintaraphan, M; Keadkraichaiwat, I; Maikaew, P; Pongwattanapakin, K; Sitticharoon, C; Sripong, C; Sririwichitchai, R; Tapechum, S | 1 |
| Ahn, SY; Cho, YK; Choi, C; Jung, YS; Kwon, SW; Lee, YH; Son, Y; Song, HD; Yoon, YC | 1 |
| Ghosh, S; Manchala, S; Raghunath, M; Sharma, G; Singh, AK; Sinha, JK | 1 |
| Huang, JA; Li, YL; Liu, ZH; Ouyang, J; Wang, QY; Wu, JL; Zhou, F; Zhu, MZ | 1 |
| Ohnishi, M; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T | 1 |
| Ashfaq, UA; Ijaz, B; Javaid, MS; Latief, N | 1 |
| Chang, JM; Chen, CH; Chien, MY; Ku, YH; Yang, CM | 1 |
| Haghighatdoost, F; Hariri, M; Nobakht M Gh, BF | 1 |
| Huang, S; Li, R; Li, X; Liu, X; Mi, Y; Qi, G; Tian, H; Zhang, W | 1 |
| Braga, CBM; Cortes-Oliveira, C; Marchini, JS; Nicoletti, CF; Nonino, CB; Noronha, NY; Oliveira, BAP; Oliveira, WP; Pinhel, MAS; Quinhoneiro, DCG; Salgado Junior, W | 1 |
| Bae, UJ; Chae, BM; Chae, SW; Jung, SJ; Oh, MR; Park, BH; Park, IW; Park, J; Ryu, GS | 1 |
| Bendik, I; Blaak, EE; Boekschoten, MV; de Groot, P; Friedel, A; Goossens, GH; Jocken, JWE; Most, J; Warnke, I | 1 |
| Li, J; Liu, H; Liu, X; Mi, Y; Qi, G; Tian, H | 1 |
| Hibi, M; Iwasaki, M; Katsuragi, Y; Osaki, N; Takase, H | 1 |
| Bae, J; Fujino, K; Hikida, A; Hirashima, A; Kadomatsu, M; Kumazoe, M; Lin, IC; Maeda-Yamamoto, M; Murata, K; Murata, M; Nakahara, K; Nezu, A; Sato, Y; Tachibana, H; Yamada, S; Yamashita, S; Yoshitomi, R | 1 |
| De Oliveira, BAP; Marchini, JS; Nicoletti, CF; Nonino, CB; Noronha, NY; Pinhanelli, VC; Pinhel, MS; Quinhoneiro, DCG | 1 |
| Alexandre, EC; André, DM; Antunes, E; Calixto, MC; Horimoto, CM | 1 |
| Chen, B; Meng, Q; Zhang, L; Zhang, S; Zhang, Y; Zhou, J | 1 |
| Mao, L; Wang, Y; Xu, P; Zhou, J | 1 |
| Casanova, E; Crescenti, A; Gibert-Ramos, A; Salvadó, J | 1 |
| Azuma, M; Dat Le, T; Hiraki, N; Inoue, YH; Omura, F; Yamanaka, M; Yoshimoto, Y | 1 |
| An, HM; Huang, JA; Lin, HY; Liu, ZH; Ou, XC; Wen, BB; Xiong, YF; Yang, Z; Zhang, YB; Zhu, MZ | 1 |
| Blaak, EE; Boekschoten, M; Fazelzadeh, P; Hankemeier, T; Hoefsloot, HCJ; Kersten, S; Most, J; van Duynhoven, J | 1 |
| de Oliveira, BAP; Delfino, HBP; Marchini, JS; Nicoletti, CF; Nonino, CB; Noronha, NY; Pinhanelli, VC; Pinhel, M; Quinhoneiro, DCG | 1 |
| Carrasco-Pozo, C; Cires, MJ; Gotteland, M | 1 |
| Ashida, AH; Nagayasu, H; Ueda-Wakagi, M; Yamashita, Y | 1 |
| Cunha, CA; da Silva, CM; de Oliveira Carvalho, P; de Souza, CT; Lira, FS; Oller do Nascimento, CM; Oyama, LM; Pimentel, GD; Ribeiro, EB; Rodrigues, B; Rosa Neto, JC; Sawaya, AC; Souza, GI | 1 |
| Ahn, S; Bae, JH; Bae, KC; Cho, HC; Choi, YJ; Im, SS; Kim, SP; Kim, YW; Park, JH; Song, DK | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| Claudia, S; Donini, LM; Edda, C; Emanuela, C; Faliva, M; Fioravanti, M; Klersy, C; Luciano, S; Maddalena, P; Opizzi, A; Paola, C; Perna, S; Rondanelli, M; Solerte, SB | 1 |
| Goda, T; Mochizuki, K; Suzuki, T; Uchiyama, Y | 1 |
| Alcorta, P; Barrenechea, L; Labayen, I; Larrarte, E; Margareto, J; Mielgo-Ayuso, J | 1 |
| Bapat, P; Chen, L; Kwun, I; Mo, H; Moustaid-Moussa, N; Shastri, A; Shen, CL; Su, R; Wang, S | 1 |
| Huang, J; Wan, X; Wang, Y; Xie, Z; Zhang, Y; Zhou, Y | 1 |
| Bajerska, J; Mildner-Szkudlarz, S; Walkowiak, J | 1 |
| Jia, Y; Lee, SJ | 1 |
| Mullin, GE | 1 |
| do Nascimento, CO; Lira, F; Mennitti, L; Okuda, M; Oyama, L; Ribeiro, E; Santamarina, A; Santana, A; Seelaender, M; Souza, G; Venancio, D | 1 |
| Carvalho-Silva, M; do Nascimento, CM; Gomes, LM; Lira, FS; Okuda, MH; Oyama, LM; Ribeiro, EB; Santamarina, AB; Santana, AA; Seelaender, M; Streck, EL | 1 |
| Arikawa, AY; Dostal, AM; Espejo, L; Kurzer, MS; Samavat, H; Stendell-Hollis, NR | 1 |
| Arikawa, A; Dostal, AM; Espejo, L; Kurzer, MS | 1 |
| Bendik, I; Blaak, EE; de Groot, P; Goossens, GH; Jocken, JW; Most, J; Schrauwen, P; Timmers, S; van Boekschoten, M; Warnke, I | 1 |
| Maeda-Yamamoto, M; Momose, Y; Nabetani, H | 1 |
| Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM | 1 |
| Gelling, RW; Han, W; Kek, HC; Li, H; Lim, J | 1 |
| Arikawa, A; Bedell, S; Dostal, AM; Espejo, L; Kurzer, MS; Stendell-Hollis, NR | 1 |
| Goto, S; Isemura, M; Monira, P; Nakamura, Y; Ohishi, T | 1 |
| Kurzer, MS; Newman, AR; Samavat, H; Wang, R; Wu, AH; Yuan, JM | 1 |
| Ahmedna, M; Rashid, MR; Sampath, C; Sang, S | 1 |
| Bae, J; Huang, Y; Kumazoe, M; Murata, M; Nakamura, Y; Shinoda, Y; Suzuki, T; Tachibana, H; Takamatsu, K; Toyoda, Y; Yamada, S; Yamaguchi, W; Yamashita, M; Yamashita, S | 1 |
| Avalos-Soriano, A; Basilio-Antonio, L; Bello, M; Correa-Basurto, J; Fragoso-Vázquez, J | 1 |
| Bluck, L; Brown, AL; Coverly, J; Coward, A; Hendrickx, H; Jackson, S; Lane, J; Stephen, A; Stocks, J | 1 |
| Bose, M; Ju, J; Lambert, JD; Reuhl, KR; Shapses, SA; Yang, CS | 1 |
| Kim, CT; Kim, Y; Lee, MS | 1 |
| Devaraj, S; Jialal, I; Yun, JM | 1 |
| Adams, F; Birkenfeld, AL; Böhnke, J; Boschmann, M; Jordan, J; Rahn, G; Thielecke, F | 1 |
| Jankun, J; Skrzypczak-Jankun, E | 1 |
| Aston, CE; Basu, A; Betts, NM; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Aston, CE; Basu, A; Betts, NM; Blevins, S; Du, M; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Cramer, JT; Fukuda, DH; Kendall, KL; Lockwood, CM; Moon, JR; Smith, AE; Stout, JR; Tobkin, SE | 1 |
| Baba, A; Hara, Y; Kubota, M; Moriwaki, H; Ohno, T; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Yasuda, Y | 1 |
| Choi, KM; Choi, MH; Hong, JT; Ji, SY; Lee, MK; Lee, S; Lee, YM; Lee, YS; Sin, DM; Yoo, HS; Yun, YP | 1 |
| Grove, KA; Kennett, MJ; Lambert, JD; Sae-tan, S | 2 |
| Chou, P; Hsu, CH; Huang, CJ; Liao, YL; Lin, SC; Tsai, TH | 1 |
| Brown, AL; Dadd, T; Holyoak, C; Lane, J; Mayes, AE; Nicol, B | 1 |
| Chen, YK; Cheung, C; Lee, MJ; Liu, AB; Lu, YP; Reuhl, KR; Yang, CS | 1 |
| Fukutomi, R; Imai, S; Isemura, M; Ishigami, Y; Miyoshi, N; Nakayama, T; Paeng, N; Suzuki, T; Taguchi, K; Yasui, K | 1 |
| Bogdanski, P; Jablecka, A; Pupek-Musialik, D; Stepien, M; Suliburska, J; Szulinska, M | 1 |
| Gosselin, C; Haman, F | 1 |
| Klaus, S; Pültz, S; Thöne-Reineke, C; Wolfram, S | 1 |
| Tian, W; Wang, X; Wu, X; Xiao, W; Zhang, R | 1 |
| Cheng, TO | 1 |
| Baile, CA; Della-Fera, MA; Hamrick, M; Nelson-Dooley, C | 1 |
| Dobrowolska-Zachwieja, A; Zielińska-Przyjemska, M | 1 |
| Chang, HH; Chen, CL; Kao, YH; Lee, MJ | 1 |
| Artacho, R; Cabrera, C; Giménez, R | 1 |
| Cho, CS; Choi, YJ; Kim, TG; Lee, HG; Moon, HS | 1 |
| Wolfram, S | 1 |
| Boschmann, M; Thielecke, F | 1 |
| Buckley, JD; Coates, AM; Hill, AM; Howe, PR; Ross, R; Thielecke, F | 1 |
| Hiipakka, RA; Kao, YH; Liao, S | 1 |
20 review(s) available for epigallocatechin gallate and Obesity
| Article | Year |
|---|---|
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polyphenols; Tea | 2023 |
The Intrinsic Virtues of EGCG, an
Topics: Animals; Antioxidants; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Obesity; Signal Transduction | 2020 |
Role of Phytomolecules in the Treatment of Obesity: Targets, Mechanisms and Limitations.
Topics: Adipokines; Animals; Anthocyanins; Anti-Obesity Agents; Benzoquinones; Catechin; Citrates; Drug Discovery; Drug Therapy, Combination; Energy Metabolism; Enzyme Inhibitors; Flavonoids; Humans; Lipids; Obesity; Phytochemicals; Phytohemagglutinins; Plant Extracts; Plants; Signal Transduction; Tannins | 2021 |
Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation.
Topics: Animals; Catechin; Colorectal Neoplasms; Humans; Inflammation; Obesity; Phytochemicals; Receptor Protein-Tyrosine Kinases; Tea | 2017 |
Effect of green tea on plasma leptin and ghrelin levels: A systematic review and meta-analysis of randomized controlled clinical trials.
Topics: Catechin; Ghrelin; Humans; Leptin; Obesity; Plant Extracts; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tea | 2018 |
Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials.
Topics: Abdominal Fat; Adult; Camellia sinensis; Catechin; Female; Humans; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Phytotherapy; Plant Extracts; Subcutaneous Fat; Tea; Treatment Outcome | 2018 |
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Epigenesis, Genetic; Glucose; Homeostasis; Humans; Lipid Metabolism; Muscle, Skeletal; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction | 2019 |
Quercetin and Epigallocatechin Gallate in the Prevention and Treatment of Obesity: From Molecular to Clinical Studies.
Topics: Adipose Tissue; Animals; Catechin; Humans; Obesity; Quercetin | 2019 |
Novel insights of dietary polyphenols and obesity.
Topics: Adipocytes; Animals; Catechin; Cell Differentiation; Curcumin; Diet; Humans; Obesity; Plant Extracts; Polyphenols; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Tea | 2014 |
The anti-obesity effects of green tea in human intervention and basic molecular studies.
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Antioxidants; Camellia sinensis; Catechin; Child; Humans; Lipid Metabolism; Middle Aged; Obesity; Phytotherapy; Polyphenols; Tea; Weight Loss; Young Adult | 2014 |
The effect of bioactive compounds in tea on lipid metabolism and obesity through regulation of peroxisome proliferator-activated receptors.
Topics: Acyclic Monoterpenes; Animals; Catechin; Humans; Lipid Metabolism; Monoterpenes; Obesity; Peroxisome Proliferator-Activated Receptors; Tea | 2015 |
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.
Topics: Body Mass Index; Catechin; Cholesterol, LDL; Humans; Obesity; Plant Extracts; Randomized Controlled Trials as Topic; Tea | 2016 |
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.
Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea | 2016 |
Anti-inflammatory Action of Green Tea.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Inflammation Mediators; Neoplasms; Neurodegenerative Diseases; Obesity; Reactive Oxygen Species; Tea | 2016 |
All teas are not created equal: the Chinese green tea and cardiovascular health.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Catechin; Diabetes Mellitus; Endothelium, Vascular; Humans; Metabolic Syndrome; Obesity; Phytotherapy; Plant Extracts; Tea | 2006 |
Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Anti-Obesity Agents; Apoptosis; Bone Marrow; Catechin; Cell Differentiation; Ciliary Neurotrophic Factor; Disulfides; Flavonoids; Humans; Leptin; Linoleic Acid; Mesenchymal Stem Cells; Obesity; Osteoporosis; Plant Extracts; Sulfoxides; Tumor Necrosis Factor-alpha | 2005 |
Tea, obesity, and diabetes.
Topics: Adipocytes; Animals; Apoptosis; Body Weight; Catechin; Cell Differentiation; Cell Division; Diabetes Mellitus; Eating; Energy Metabolism; Fatty Acids; Hormones; Humans; Lipids; Lipolysis; Obesity; Oxidation-Reduction; Receptors, Laminin; Tea | 2006 |
Beneficial effects of green tea--a review.
Topics: Anticarcinogenic Agents; Antihypertensive Agents; Antimutagenic Agents; Antioxidants; Biological Availability; Camellia sinensis; Cardiovascular Diseases; Catechin; Flavonoids; Health Promotion; Humans; Nutritive Value; Obesity; Phenols; Polyphenols; Tea | 2006 |
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.
Topics: Adipocytes; AMP-Activated Protein Kinases; Animals; Antioxidants; Catechin; Extracellular Signal-Regulated MAP Kinases; Humans; Multienzyme Complexes; Obesity; Plant Extracts; Protein Serine-Threonine Kinases; Tea | 2007 |
Effects of green tea and EGCG on cardiovascular and metabolic health.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Humans; Insulin Resistance; Obesity; Tea | 2007 |
26 trial(s) available for epigallocatechin gallate and Obesity
| Article | Year |
|---|---|
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial.
Topics: Adult; Body Mass Index; Catechin; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Placebos; Tea | 2021 |
Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study.
Topics: Adipose Tissue; Adult; Antioxidants; Butyrylcholinesterase; Catechin; Coconut Oil; Dietary Supplements; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Multiple Sclerosis; Obesity; Pilot Projects; Weight Loss | 2021 |
Green tea catechin EGCG could prevent obesity-related precocious puberty through NKB/NK3R signaling pathway.
Topics: Animals; Camellia sinensis; Catechin; Female; Humans; Neurokinin B; Obesity; Puberty, Precocious; Rats; Retrospective Studies; Signal Transduction | 2022 |
The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats.
Topics: Animals; Catechin; Diet, High-Fat; Humans; Inflammation; Lipid Metabolism; Longevity; Male; Obesity; Oxidative Stress; Phytochemicals; Rats; Rats, Wistar | 2020 |
Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects.
Topics: Adipocytes, Brown; Adipocytes, White; Adiponectin; Adult; Blood Glucose; Blood Pressure; Catechin; Humans; Kidney; Kisspeptins; Leptin; Lipolysis; Liver; Middle Aged; Obesity; RNA, Messenger; Triglycerides; Uncoupling Protein 1 | 2021 |
The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans.
Topics: Adipose Tissue; Adult; Catechin; Dietary Supplements; Double-Blind Method; Female; Gene Expression; Humans; Male; Obesity; Overweight; Polyphenols; Resveratrol | 2018 |
Global testing of shifts in metabolic phenotype.
Topics: Catechin; Dietary Supplements; Double-Blind Method; Humans; Metabolomics; Obesity; Phenotype; Resveratrol; Weight Loss | 2018 |
Acute effect on satiety, resting energy expenditure, respiratory quotient, glucagon-like peptide-1, free fatty acids, and glycerol following consumption of a combination of bioactive food ingredients in overweight subjects.
Topics: Adult; Alkaloids; Area Under Curve; Basal Metabolism; Benzodioxoles; Capsaicin; Carnitine; Catechin; Dietary Supplements; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucagon-Like Peptide 1; Glycerol; Humans; Male; Middle Aged; Obesity; Phytotherapy; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Satiation; Satiety Response | 2013 |
Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Topics: Adult; Anti-Obesity Agents; Antioxidants; Body Mass Index; Camellia sinensis; Catechin; Diet, Reducing; Dietary Supplements; Double-Blind Method; Energy Metabolism; Female; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Middle Aged; Obesity; Plant Extracts; Plant Leaves; Risk Factors; Spain; Young Adult | 2014 |
Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
Topics: Blood Pressure; Body Mass Index; Body Weight Maintenance; Bread; Caffeine; Camellia sinensis; Catechin; Diet, Reducing; Edible Grain; Energy Intake; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Secale; Single-Blind Method; Waist Circumference; Weight Loss | 2015 |
Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.
Topics: Adiponectin; Administration, Oral; Aged; Blood Glucose; Body Mass Index; Body Weight; Caffeine; Catechin; Catechol O-Methyltransferase; Double-Blind Method; Energy Intake; Fasting; Female; Genotype; Ghrelin; Humans; Insulin; Leptin; Middle Aged; Motor Activity; Nutrition Assessment; Obesity; Overweight; Plant Extracts; Polyphenols; Postmenopause; Tea; Waist Circumference | 2016 |
Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.
Topics: Adipose Tissue; Adiposity; Body Composition; Body Mass Index; Bone and Bones; Bone Density; Caffeine; Camellia sinensis; Catechin; Catechol O-Methyltransferase; Dietary Supplements; Double-Blind Method; Female; Genotype; Humans; Middle Aged; Obesity; Overweight; Plant Extracts; Postmenopause; Tea | 2016 |
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Topics: Adult; Blood Glucose; Catechin; Dietary Supplements; Double-Blind Method; Energy Metabolism; Fasting; Female; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Mitochondria; Muscles; Obesity; Plant Extracts; Postprandial Period; Resveratrol; Stilbenes | 2016 |
Green tea extract and catechol-O-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women.
Topics: Adiponectin; Aged; Antioxidants; Body Mass Index; Catechin; Catechol O-Methyltransferase; Dietary Supplements; Double-Blind Method; Female; Genotype; Ghrelin; Humans; Insulin; Leptin; Middle Aged; Obesity; Overweight; Plant Extracts; Postmenopause; Postprandial Period; Surveys and Questionnaires; Tea | 2017 |
Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.
Topics: Antioxidants; Biomarkers; Body Mass Index; Catechin; Catechol O-Methyltransferase; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Female; Humans; Lipids; Middle Aged; Obesity; Plant Extracts; Postmenopause; Tea; Treatment Outcome; Triglycerides | 2016 |
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
Topics: Adult; Affect; Aged; Antihypertensive Agents; Catechin; Diastole; Dietary Supplements; Double-Blind Method; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Treatment Failure | 2009 |
Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study.
Topics: Adult; Antioxidants; Caffeine; Catechin; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Energy Metabolism; Fasting; Humans; Lipid Peroxidation; Male; Obesity; Overweight; Pilot Projects; Plant Extracts; Postprandial Period; Young Adult | 2010 |
Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.
Topics: Adult; Aldehydes; Biological Availability; Body Mass Index; Body Weight; Camellia sinensis; Case-Control Studies; Catechin; Cholesterol; Female; Humans; Hypolipidemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Metabolic Syndrome; Obesity; Patient Compliance; Phytotherapy; Plant Extracts; Single-Blind Method | 2010 |
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Camellia sinensis; Cardiovascular Diseases; Catechin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Single-Blind Method; Tea; Vascular Cell Adhesion Molecule-1 | 2011 |
Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise in overweight and obese women.
Topics: Adolescent; Adult; Antioxidants; Body Composition; Caffeine; Cardiovascular Physiological Phenomena; Catechin; Combined Modality Therapy; Exercise; Female; Humans; Lipids; Middle Aged; Obesity; Phosphodiesterase Inhibitors; Physical Endurance; Physical Fitness; Young Adult | 2010 |
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
Topics: Adult; Antioxidants; Body Mass Index; Catechin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Obesity; Prospective Studies; Tea; Treatment Outcome; Waist-Hip Ratio; Weight Loss; Young Adult | 2011 |
Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial.
Topics: Adult; Aged; Alleles; Base Sequence; Biomarkers; Cardiotonic Agents; Catechin; Catechol O-Methyltransferase; Cross-Over Studies; DNA Primers; Double-Blind Method; Genotype; Humans; Male; Middle Aged; Obesity; Overweight; Tea | 2011 |
Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients.
Topics: Adult; Antioxidants; Blood Glucose; Catechin; Dietary Supplements; Female; Humans; Lipids; Male; Middle Aged; Obesity; Oxidative Stress; Tea | 2012 |
Effects of green tea extracts on non-shivering thermogenesis during mild cold exposure in young men.
Topics: Adult; Area Under Curve; Caffeine; Camellia sinensis; Catechin; Cold Temperature; Diabetes Mellitus; Diet; Energy Metabolism; Humans; Male; Obesity; Plant Extracts; Shivering; Tea; Thermogenesis; Young Adult | 2013 |
The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study.
Topics: Adipose Tissue; Adult; Antioxidants; Basal Metabolism; Catechin; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Humans; Male; Obesity; Oxidation-Reduction; Oxygen Consumption; Pilot Projects; Plant Extracts; Tea; Thermogenesis; Weight Loss | 2007 |
Can EGCG reduce abdominal fat in obese subjects?
Topics: Abdominal Fat; Aged; Blood Glucose; Body Composition; Body Mass Index; Catechin; Dietary Supplements; Female; Health Status; Heart Rate; Humans; Middle Aged; Obesity; Overweight; Postmenopause; Treatment Outcome; Waist-Hip Ratio; Walking; Weight Loss | 2007 |
52 other study(ies) available for epigallocatechin gallate and Obesity
| Article | Year |
|---|---|
RNA-seq profiling of white and brown adipocyte differentiation treated with epigallocatechin gallate.
Topics: Adipocytes, Brown; Adipocytes, White; Anti-Obesity Agents; Catechin; Cell Differentiation; Humans; Obesity; RNA-Seq | 2022 |
EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat diet.
Topics: Animals; Antioxidants; Catechin; Diet, High-Fat; Gastrointestinal Microbiome; Liver; Male; Metabolome; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Tea; Tyrosine | 2022 |
Prenatal EGCG consumption causes obesity and perturbs glucose homeostasis in adult mice.
Topics: Adult; Animals; Catechin; Female; Glucose; Homeostasis; Male; Mice; Mice, Inbred C57BL; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Receptor, Insulin | 2023 |
Tea polyphenol EGCG ameliorates obesity-related complications by regulating lipidomic pathway in leptin receptor knockout rats.
Topics: Animals; Catechin; Cholesterol; Glycerophospholipids; Lipidomics; Liver; Obesity; Polyphenols; Rats; Receptors, Leptin; Tea; Triglycerides | 2023 |
EGCG alleviates obesity-exacerbated lung cancer progression by STAT1/SLC7A11 pathway and gut microbiota.
Topics: Animals; Carcinogenesis; Diet, High-Fat; Gastrointestinal Microbiome; Leptin; Lung; Lung Neoplasms; Mice; Mice, Inbred C57BL; Obesity; Urethane | 2023 |
Beneficial effects of green tea on age related diseases.
Topics: Aging; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Functional Food; Humans; Metabolic Syndrome; Obesity; Plant Extracts; Tea | 2020 |
Green Tea Polyphenol (-)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced Obese Mice.
Topics: Animals; Anti-Obesity Agents; Catechin; Cell Line; Diet, High-Fat; Disease Models, Animal; Hypothalamus; Inflammation; Interleukin-1beta; Interleukin-6; Janus Kinase 2; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; Obesity; Palmitic Acid; Polyphenols; STAT3 Transcription Factor; Tea; Tumor Necrosis Factor-alpha | 2019 |
Calorimetric approach for comparison of Angiopoietin-like protein 4 with other pancreatic lipase inhibitors.
Topics: Angiopoietin-Like Protein 4; Anti-Obesity Agents; Calorimetry; Catechin; Drug Evaluation, Preclinical; Enzyme Assays; Humans; Lipase; Obesity; Orlistat; Polylysine; Recombinant Proteins | 2020 |
Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches.
Topics: Animals; Anti-Obesity Agents; Carbohydrate Metabolism; Catechin; Cholestenones; Drugs, Chinese Herbal; Enzyme Assays; Flavanones; Glucosides; Humans; Molecular Docking Simulation; Obesity; Pancreatic alpha-Amylases; Swine; Weight Loss | 2020 |
Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
Topics: Animals; Apoptosis; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Hepatocytes; Humans; Linoleic Acid; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2021 |
Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues.
Topics: Adipose Tissue, White; Adiposity; Animals; Autophagy; Beclin-1; Catechin; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation, Developmental; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity | 2020 |
Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism.
Topics: Animals; Anti-Obesity Agents; Bile Acids and Salts; Caffeine; Catechin; Cholesterol 7-alpha-Hydroxylase; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Volatile; Feces; Gastrointestinal Microbiome; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled | 2021 |
Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designing.
Topics: Adipocytes; Camellia sinensis; Catechin; Cell Differentiation; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Obesity; Polyphenols; PPAR gamma; Tea; Transcription Factors | 2018 |
Effects of herbal mixture extracts on obesity in rats fed a high-fat diet.
Topics: Animals; Anti-Obesity Agents; Catechin; Diet, High-Fat; Obesity; Rats | 2016 |
EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition.
Topics: Active Transport, Cell Nucleus; Animals; Catechin; Heme Oxygenase-1; Humans; Insulin; Insulin Resistance; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Signal Transduction | 2018 |
Green tea supplementation upregulates uncoupling protein 3 expression in severe obese women adipose tissue but does not promote weight loss.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Body Mass Index; Catechin; Dietary Supplements; Humans; Longitudinal Studies; Middle Aged; Obesity; Perilipin-1; Plant Extracts; PPAR gamma; Receptors, Adrenergic, beta-3; Tea; Uncoupling Protein 1; Uncoupling Protein 3; Up-Regulation; Weight Loss; Young Adult | 2018 |
Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
Topics: Animals; Catechin; Cell Survival; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Obesity; Phytotherapy; Plant Extracts; Sirtuin 1; Tea; Weight Gain | 2018 |
EGCG stimulates the recruitment of brite adipocytes, suppresses adipogenesis and counteracts TNF-α-triggered insulin resistance in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipocytes, Beige; Adipogenesis; Animals; Catechin; Insulin Resistance; Mice; Obesity; Oxidative Stress; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Uncoupling Protein 1 | 2018 |
Saturated fatty acid attenuates anti-obesity effect of green tea.
Topics: Adipose Tissue, White; Animals; Catechin; Diet, High-Fat; Fatty Acids; Male; Meat; Mice; Mice, Inbred C57BL; Obesity; Olive Oil; Plant Extracts; PPAR gamma; Tea; Weight Gain | 2018 |
Green tea supplementation promotes leukocyte telomere length elongation in obese women.
Topics: Adult; Body Mass Index; Catechin; Cross-Sectional Studies; Dietary Supplements; Female; Humans; Leukocytes; Middle Aged; Obesity; Tea; Telomere; Telomere Shortening | 2018 |
Epigallocatechin-3-gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice.
Topics: Animals; Antioxidants; Asthma; Catechin; Disease Models, Animal; Eosinophils; Inflammation; Lung; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress | 2018 |
Comparative analysis of fecal phenolic content between normal and obese rats after oral administration of tea polyphenols.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camellia sinensis; Catechin; Dietary Supplements; Feces; Fermentation; Food Handling; Gastrointestinal Microbiome; Intestinal Absorption; Intestinal Elimination; Male; Obesity; Oxidation-Reduction; Phenols; Phenylacetates; Plant Extracts; Plant Leaves; Polyphenols; Random Allocation; Rats, Sprague-Dawley | 2018 |
Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet.
Topics: Adipose Tissue, Brown; Animals; Biomarkers; Blood Glucose; Catechin; Cholesterol; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Hypothalamus; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; NF-kappa B; Obesity; Polyphenols; STAT3 Transcription Factor; Tea; Triglycerides | 2018 |
RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults.
Topics: Animals; Anti-Obesity Agents; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Glucosides; Humans; Lipid Metabolism; Male; Metabolomics; Obesity; Oxidative Stress; Quercetin; RNA-Seq; RNA, Messenger; Species Specificity | 2019 |
Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
Topics: Animals; Body Weight; Caffeine; Catechin; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tea | 2019 |
Impact of green tea epigallocatechin-3-gallate on HIF1-α and mTORC2 expression in obese women: anti-cancer and anti-obesity effects?
Topics: Adolescent; Adult; Anti-Obesity Agents; Anticarcinogenic Agents; Catechin; Class Ia Phosphatidylinositol 3-Kinase; Dietary Supplements; Female; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mechanistic Target of Rapamycin Complex 2; Middle Aged; Obesity; Phosphatidylinositol 3-Kinases; Young Adult | 2019 |
Green Tea Ameliorates Hyperglycemia by Promoting the Translocation of Glucose Transporter 4 in the Skeletal Muscle of Diabetic Rodents.
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diet, High-Fat; Fructosamine; Glucose; Glucose Intolerance; Glucose Tolerance Test; Glucose Transporter Type 4; Glycated Hemoglobin; Hyperglycemia; Lipids; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Plant Extracts; Rats; Rats, Wistar; Rodentia; Streptozocin; Tea | 2019 |
Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet.
Topics: Adiponectin; Animals; Catechin; Chromatography, High Pressure Liquid; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Interleukin-10; Lipolysis; Mice; Myeloid Differentiation Factor 88; Obesity; Tea; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2013 |
Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Obesity Agents; Caco-2 Cells; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Plant Extracts; Polyethylene Glycols; Retinol-Binding Proteins, Plasma | 2013 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Inflammation; Male; Obesity; Oxidative Stress; Rats; Rats, Wistar | 2013 |
Supplements for weight loss: hype or help for obesity? Part III.
Topics: Amorphophallus; Catechin; Dietary Fiber; Dietary Supplements; Fish Oils; Galactans; Garcinia cambogia; Humans; Mannans; Meta-Analysis as Topic; Obesity; Panax; Plant Gums; Plant Roots; Psyllium; Tea; Trigonella; Weight Loss | 2015 |
Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Topics: Absorption, Physicochemical; Adipose Tissue, White; Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Brazil; Camellia sinensis; Catechin; Diet, High-Fat; Dietary Supplements; Food Handling; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Male; Mice; Obesity; Plant Extracts; Plant Leaves; Random Allocation; Weight Gain | 2015 |
Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
Topics: Animals; Body Weight; Catechin; Cytokines; Diet, High-Fat; Dietary Supplements; Enzymes; Glucose Tolerance Test; Insulin Resistance; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Tea | 2015 |
Green tea (-)-epigallocatechin-3-gallate counteracts daytime overeating induced by high-fat diet in mice.
Topics: Animals; Antioxidants; Catechin; Diet, High-Fat; Disease Models, Animal; Feeding Behavior; Homeostasis; Hyperphagia; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Tea | 2016 |
Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity.
Topics: Animals; Catechin; Diet, High-Fat; Glycation End Products, Advanced; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Obesity; Random Allocation; Signal Transduction; Tea | 2017 |
Green Tea Polyphenol Epigallocatechin-3-gallate Suppresses Toll-like Receptor 4 Expression via Up-regulation of E3 Ubiquitin-protein Ligase RNF216.
Topics: Animals; Catechin; Cells, Cultured; Gene Expression Regulation; Hyperinsulinism; Hypertriglyceridemia; Inflammation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Obesity; Receptors, Laminin; Signal Transduction; Tea; Toll-Like Receptor 4; Transcriptional Activation; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Up-Regulation | 2017 |
Molecular recognition between pancreatic lipase and natural and synthetic inhibitors.
Topics: Catechin; Enzyme Inhibitors; Humans; Kinetics; Lactones; Ligands; Lipase; Molecular Dynamics Simulation; Obesity; Orlistat; Pancreas | 2017 |
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Catechin; Diet; Dietary Fats; Eating; Fatty Liver; Feces; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Tea | 2008 |
Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Topics: Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Catechin; Dietary Fats; Dose-Response Relationship, Drug; Epididymis; Gene Expression Regulation; Lipid Metabolism; Lipolysis; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Thermogenesis; Triglycerides | 2009 |
Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Blotting, Western; Camellia sinensis; Case-Control Studies; Catechin; Cell Culture Techniques; Enzyme-Linked Immunosorbent Assay; Epigenesis, Genetic; Female; Flow Cytometry; Forkhead Transcription Factors; Histone Deacetylases; Humans; Interleukin-10; Male; Middle Aged; Obesity; Phytotherapy; Plant Extracts; T-Lymphocytes, Regulatory; Thinness; Transcription Factor RelA; Young Adult | 2010 |
Theaflavin digallate inactivates plasminogen activator inhibitor: could tea help in Alzheimer's disease and obesity?
Topics: Alzheimer Disease; Biflavonoids; Catechin; Electrophoresis, Polyacrylamide Gel; Gallic Acid; Humans; Indoleacetic Acids; Mutation; Obesity; Plasminogen Activator Inhibitor 1; Protein Binding; Tea; Thrombelastography; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2010 |
Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Diabetes Mellitus, Experimental; Diethylnitrosamine; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Nonesterified; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Obesity; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1 | 2011 |
Inverse relationship between adipocyte differentiation and ceramide level in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Catechin; Ceramides; Lipid Metabolism; Mice; Molecular Targeted Therapy; Obesity; Sphingosine; Triglycerides | 2011 |
(-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice.
Topics: Animals; Antioxidants; Body Weight; Catechin; Diet, High-Fat; Feces; Lipase; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity | 2012 |
(-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice.
Topics: Adipose Tissue; Animals; Antioxidants; Cadherins; Catechin; Diet, High-Fat; Dietary Fats; Gene Expression; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Muscle, Skeletal; Nuclear Respiratory Factor 1; Obesity; Oxidation-Reduction; PPAR alpha; Uncoupling Protein 3; Weight Gain | 2011 |
Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
Topics: Animals; Blood Glucose; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Polyphenols | 2011 |
Effects of a catechin-free fraction derived from green tea on gene expression of enzymes related to lipid metabolism in the mouse liver.
Topics: Animals; Arteriosclerosis; Blood Glucose; Catechin; Cholesterol; Down-Regulation; Glucose-6-Phosphatase; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred BALB C; Obesity; Phosphoenolpyruvate Carboxykinase (ATP); Plant Extracts; Plant Leaves; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Tea; Triglycerides | 2012 |
Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation.
Topics: Animals; Antioxidants; Body Composition; Body Temperature; Calorimetry, Indirect; Carrier Proteins; Catechin; Dietary Supplements; Eating; Glucokinase; Intestinal Absorption; Ion Channels; Leptin; Lipid Metabolism; Malate Dehydrogenase; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred NZB; Mitochondrial Proteins; Obesity; Oxidation-Reduction; Pyruvate Kinase; Stearoyl-CoA Desaturase; Tissue Distribution; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3 | 2005 |
Novel inhibitors of fatty-acid synthase from green tea (Camellia sinensis Xihu Longjing) with high activity and a new reacting site.
Topics: Camellia sinensis; Catechin; Enzyme Inhibitors; Fatty Acid Synthases; Flavonoids; Inhibitory Concentration 50; Obesity; Phenols; Plant Extracts; Polyphenols; Tea | 2006 |
[Effect of tea polyphenols on oxidative metabolism of polymorphonuclear neutrophils in healthy and obese people].
Topics: Adult; Antioxidants; Biflavonoids; C-Reactive Protein; Case-Control Studies; Catechin; Female; Flavonoids; Gallic Acid; Humans; Hydrogen Peroxide; In Vitro Techniques; Luminescence; Male; Middle Aged; Neutrophils; Nitric Oxide; Obesity; Oxidative Stress; Phenols; Polyphenols; Reactive Oxygen Species; Tea; Tetradecanoylphorbol Acetate | 2005 |
Modulation of obesity by a green tea catechin.
Topics: Animals; Catechin; Female; Humans; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Tea | 2000 |